Behind the Science 2021 - From funding stream to blood stream: Is drug development moving fast enough? 2021Sean RichardsJune 11, 2021
Adrestia Therapeutics secures Series A funding from global pharmacy company GSK 2020Sean RichardsDecember 21, 2020
Hear our own Soren Hough discuss the ethics and risks of heritable genome editing with CRISPR 2020Sean RichardsAugust 6, 2020
Steve awarded the Fondation ARC Léopold Griffuel Award in Translational and Clinical Research 2019Sean RichardsFebruary 19, 2019
Novel mechanisms of drug resistance in ATM-deficient cells suggest potential new therapies for cancer and ataxia-telangiectasia 2019Sean RichardsJanuary 8, 2019
Steve discusses how blue skies research will influence future cancer therapies 2019Sean RichardsJanuary 8, 2019
We, with a group of international collaborators, have identified a novel protein complex (Shieldin) that promotes DNA repair in cells lacking the HR protein BRCA1. Loss of Shieldin restores genome stability in BRCA1 deficiency Read More 2018Sean RichardsJuly 19, 2018
Our new paper on "Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells.." is a Focus feature in Science Signaling 2018Sean RichardsJuly 4, 2018
Sébastien Britton, Jackson lab postdoc Jan 2010-April 2013, awarded 2018 CNRS Bronze medal 2018Sean RichardsApril 5, 2018
Cancer patient Sandy meets Steve Jackson and explains how the ground-breaking drug Lynparza saved her life. 2018Sean RichardsJanuary 16, 2018
FDA approves first treatment for breast cancer with a certain inherited genetic mutation 2018Sean RichardsJanuary 12, 2018